Stockreport

GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

GRI Bio, Inc.  (GRI) 
PDF GRI-0803 systemic lupus erythematosus (SLE) program advancing towards completion of Investigational New Drug (IND) Application enabling studies with IND filing on track [Read more]